Publication
Sgouropoulou D, et al. Midlife physical activity trajectories are associated with reduced physical pre-frailty/frailty in older age: ATTICA 2002-2024. J Frailty Aging, 2026
PMID 42895852
Проспективная популяционная когорта ATTICA (Аттика, Греция), 574 взрослых, средний возраст на старте 48 лет, наблюдение 22 года. Активность (анкета IPAQ, порог 600 МЕТ-мин/нед) на старте, через 5 и 10 лет. По сравнению с постоянно неактивными: ставшие активными ОР 0,21 (0,12–0,36), активные все время ОР 0,20 (0,11–0,37) для преастении/астении по шкале FRAIL; бросившие 1,28 (0,69–2,38). Наблюдательное исследование, активность и хрупкость со слов участников, большое выбывание.
Also in the catalogue
- Skoulidis F, Ahn MJ, Gadgeel S, et al. Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C-Mutated NSCLC (Krascendo 1). N Engl J Med, 2026Publication
- Liu J, Yi T, Xing P, et al. Trial of Endovascular Therapy for Mild Stroke with Large-Vessel Occlusion (MILD-MT). N Engl J Med, 2026Publication
- Kanazawa H, et al. Additive effects of active vitamin D3 or vitamin E administration on therapeutic lower-limb home exercise for knee osteoarthritis: a pilot prospective randomized controlled trial. Medicine (Baltimore), 2026Publication
- Yang S, Wang H, Liu Y, et al. Clinical Pathway Management for Platelet-Rich Plasma Therapy in Kellgren-Lawrence Grade I and II Knee Osteoarthritis. Am J Sports Med, 2026Publication
- Shaik J, Zhang W, Zentsch V, et al. Remote Versus In-Person Follow-up Programming After Subthalamic Deep Brain Stimulation for Parkinson's Disease. Mov Disord, 2026Publication
- Seliger SL, Gitomer B, You Z, et al. Empagliflozin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Randomized Controlled Trial. J Am Soc Nephrol, 2026Publication
Scales
Identifiers
- PMID
- 42895852
- DOI
- 10.1016/j.tjfa.2026.100217
Original sources
Details
- Journal
- J Frailty Aging
- Year
- 2026
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.